FindTrial
Sign In

Radiofrequency therapy at 448 kHz for persisting pain after episiotomy * a pilot study

Radiofrequency therapy at 448 kHz for persisting pain after episiotomy * a pilot study - EPI-448

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51265
Enrollment
32
Registered
2021-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

episiotomy vaginal cut

Interventions

All participants receive a total of 7 MCRRF treatments at a rate of 1 session per week.

Sponsors

Ikazia Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Age * 18 years 2. Persisting pain in the pelvic floor region (VAS-score * 4) after a mediolateral episiotomy 3. At least 6 weeks after delivery

Exclusion criteria

Exclusion criteria: 1. Signs of infection of the episiotomy wound 2. Pacemaker or other electronical implant 3. Nickel allergy 4. Pregnancy

Design outcomes

Primary

MeasureTime frame
The primary endpoint is to compare VAS scores before and after MCRRF therapy.—

Secondary

MeasureTime frame
Secondary endpoints are reassumption of sexual intercourse and analgesics intake.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)